coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Chanctonbury PCN, Horsham · Health Inequalities Profile

    PCN U57981 · NHS Surrey and Sussex Integrated Care Board; NHS Sussex Integrated Care Board · 4 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    48,532

    Registered population

    53.5% aged 18–64

    29.0%

    Aged 65+

    ICB 21.9% · England 17.9%

    3.6%

    Ethnic minority (non-White)

    1.2% Asian · England 9.6%

    0.0%

    In IMD quintile 1

    ICB 9.2% · England 21.0%

    0

    Core20 residents (est.)

    Resident basis; registered basis 0 · see page 3

    9,495

    Hypertension register

    +6.84% in 3 yrs · England +5.60%

    385

    SMI register

    30.3% of Horsham's

    868

    COPD register

    Reviews +3.04% in 3 yrs

    Forecast to 2030

    11,178

    Hypertension patients, 2030

    +1,683 on today

    73.1%

    QRISK ≥20% on statins, 2030

    +5.22pp over 3 yrs

    7.0%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    58.6%
    Asthma annual reviews trail England.

    Only 58.6% had a review (Horsham 62.4%, ICB 62.5%, England 65.7%), leaving about 1,400 of 3,494 patients unreviewed; this may reflect recall gaps.

    61.1%
    High-risk lipid therapy below England.

    Lipid therapy in QRISK ≥ 20% is 61.1% (England 63.6%), alongside lags in CKD (64.7% vs 70.3%) and diabetes with CVD (79.7% vs 84.4%).

    +14.0%
    Hypertension control improved faster than England.

    Treatment to target rose +14.0% from 2023 to 2025 (England +3.6%), reaching 71.5% (England 70.3%), with 91.8% having a recent blood pressure reading.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Patients aged 65+ make up 29.0% of the list, above England's 17.9%

    Chanctonbury PCN has 48,532 registered patients with an older demographic: 29.0% are aged 65+ (14,096 patients), exceeding Horsham (23.7%), NHS Sussex Integrated Care Board (21.9%), and England (17.9%). Patients aged 18–64 represent 53.5% (Horsham 57.6%, ICB 60.5%, England 62.7%) and those aged 0–17 comprise 17.4% (Horsham 18.7%, ICB 17.7%, England 19.6%). Census resident estimates, which describe local residents rather than registered patients, show 96.4% White ethnicity (Horsham 93.6%, ICB 91.0%, England 81.1%), leaving a 3.6% ethnic minority share, with 1.2% Asian and 0.3% Gypsy or Irish Traveller residents. Projected population growth to 2030 is 3.2% (unverified method).

    Age profile

    0–1717.4%
    18–6453.5%
    65+29.0%

    65+: ICB 21.9%, England 17.9%

    Ethnicity

    White96.4%
    Mixed1.6%
    Asian1.2%
    Other0.4%
    Black0.4%

    Older people · falls rows are Horsham local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Horsham LA)2,1542,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)82.4%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)63.7%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Horsham LA)9099819552024/25
    Falls deaths, all ages, per 100,000 (Horsham LA)10.514.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Average IMD decile is 7.7 with 0.0% Core20 patients across all four practices

    The PCN average IMD decile is 7.7 (Horsham 8.2, NHS Sussex Integrated Care Board 6.1, England 5.5). Across all four practices, 0.0% of registered patients are in the Core20 cohort (Horsham 0.0%, NHS Sussex Integrated Care Board 9.2%, England 21.0%), representing an estimated 0 Core20 patients. Practice deciles range from 7.2 at Henfield Medical Centre and 7.3 at Billingshurst Surgery to 8.0 at Steyning Health Centre and Glebe Surgery. Zero Core20 concentration shifts inequality focus toward clinical inclusion cohorts rather than area deprivation.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Steyning0.0% · 0 patients
    Billingshurst0.0% · 0 patients
    Henfield0.0% · 0 patients
    Glebe0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    385

    SMI register

    0.78% recorded prevalence

    265

    Learning disability register

    0.54% recorded prevalence

    14

    Care homes, 519 beds

    In the PCN catchment

    8.0%

    Provide unpaid care

    Horsham, Census 2021

    Recorded inclusion health registers capture 265 patients with a learning disability (0.5%, England 0.6%) and 385 with severe mental illness (0.8%, England 1.0%), alongside 14 catchment care homes with 519 beds. With recorded severe mental illness and learning disability prevalence trailing England rates, structured annual physical health checks and coordinated care home reviews are the primary inclusion workload to prioritise.

    Severe mental illness: physical health checks

    SMI checks reached 84.0% for blood pressure and 84.4% for BMI (England 83.4% and 82.1%). Smoking cessation offers for indicated conditions reached 88.7% (England 94.2%), trailing at Billingshurst Surgery at 71.4%.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    9,495

    Hypertension register

    +6.84%

    Register growth, 3 yrs

    Horsham +4.65% · England +5.60%

    +7.21pp

    BP control, under 80

    ≤140/90 · +4.19pp aged 80+

    +1,683

    More patients by 2030

    Forecast 11,178 (22.05%)

    Hypertension case-finding and control

    Hypertension prevalence is 19.3% (9,495 patients), above Horsham (16.8%), NHS Sussex Integrated Care Board (16.3%), and England (15.2%). Recent blood pressure monitoring reached 91.8%, exceeding England (90.0%) and the ICB (90.2%), while trailing Horsham (92.0%). Patients treated to target rose +14.0% over 2023 to 2025 (England +3.6%) to 71.5%, above England (70.3%) but below Horsham (73.8%). For patients aged under 80, control to <= 140/90 mmHg is 68.8%, trailing Horsham (71.5%) despite exceeding England (67.8%). Trailing borough-level blood pressure control among patients aged under 80 suggests potential scope to review clinical management and medication titration.

    Lipids and statins

    Lipid-lowering therapy trails England across high-risk groups: QRISK ≥ 20% reaches 61.1% (England 63.6%), CKD is 64.7% (England 70.3%), and diabetes with CVD is 79.7% (England 84.4%). Lower treatment rates compared to England across high-risk groups suggest scope to review clinical recall and therapy initiation.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026104,322£2.30£2.42£1.86£239,941
    Cardiovascular (all), 2025129,645£3.16£3.32£3.33£409,678

    In 2026, lipid-regulating drugs totalled 104,322 items at £2.30 per item, below Horsham (£2.64) and NHS Sussex Integrated Care Board (£2.42) but above England (£1.86). The PCN spent £45,902 more than at England's unit cost and £12,519 less than at the ICB's unit cost. Unit costs could reflect formulary choices rather than prescribing efficiency.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +11.19%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +5.00%

    Asthma prevalence, PCN 3-yr % change

    The asthma register includes 3,494 patients (7.5% prevalence, England 6.6%), but 12-month reviews reached 58.6%, trailing Horsham (62.4%), NHS Sussex Integrated Care Board (62.5%), and England (65.7%), leaving about 1,400 unreviewed patients. Reviews were 38.5% at Billingshurst Surgery and 72.1% at Steyning Health Centre. Recorded COPD prevalence is 1.8% (868 patients), with reviews at 66.9% trailing England (76.4%). Structured clinical recall could help address these unreviewed respiratory cohorts.

    Cancer register and children's immunisation

    Cancer prevalence is 6.0% (2,930 patients, England 3.8%). In Q1 2025/26, 12- and 24-month immunisations exceeded the 95.0% target (6-in-1 at 96.5%, MMR1 at 96.1%). At age 5, coverage was below the 95.0% target for MMR2 (88.0%) and 4-in-1 (87.0%, denominator 108), with same-cohort MMR dose differences of 8 pp at Steyning Health Centre and 5.6 pp at Glebe Surgery.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months96.5%

    England 91.0%

    6-in-1 complete primary course at 24 months96.1%

    England 92.2%

    MMR dose 1 at 24 months96.1%

    England 88.3%

    MMR dose 2 at age 588.0%

    England 82.8%

    4-in-1 pre-school booster at age 587.0%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    58.5%

    Sussex ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,360

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Sussex ICBEnglandNo usable stageStaged cancers
    Prostate56.6%53.2%19%1,668
    Breast86.1%85.4%23%1,400
    Bowel49.8%47.0%26%1,133
    Lung30.3%33.8%15%1,058
    Skin cancer95.3%87.8%17%698

    In 2022, 58.5% of cancers with a known stage in NHS Sussex ICB were diagnosed at stage 1 or 2 (4,799 of 8,209), above England (55.3%) but below the 75.0% national ambition by 2028 by 16.5 pp. Stage was known for 64.3% of 12,766 registered cancers (England 67.0%), requiring about 1,360 extra early diagnoses annually; these ICB figures reflect wider system staging rather than PCN performance, and specific cancer sites carry small-number limits. In CHANCTONBURY PCN, cancer prevalence is 6.0% (2,930 patients) and cervical screening is 76.0% (England 66.8%), but three-year register growth of +8.0% trails England (+9.0%), which clinical audit can review.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026 (provisional), University Hospitals Sussex NHS Foundation Trust achieved 65.2% on the 62-day cancer referral to treatment standard, below the 85.0% standard by 19.8 pp, trailing Surrey and Sussex Healthcare NHS Trust (70.0%), Royal Surrey NHS Foundation Trust (84.5%), NHS Surrey and Sussex Integrated Care Board (71.5%), and England (71.2%). The trust reached 74.0% for the 28-day faster diagnosis standard (standard 75.0%) and 76.8% for 31-day treatment (standard 96.0%). For diagnostics, 39.3% waited 6+ weeks for colonoscopy (England 30.8%). Secondary care delays could impede prompt diagnosis and management for referred patients.

    Pathways within standard (%)SussexSurrey and Sussex HealthcareRoyal SurreySurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)74.0177.7482.6279.2979.32
    31-day treatment (96%)76.7996.2096.4390.4592.50
    62-day referral to treatment (85%)65.2069.9784.4871.5171.16
    Diagnostic waits over 6 weeks (%)SussexSurrey and Sussex HealthcareRoyal SurreyEngland
    MRI5.6227.530.0021.40
    CT8.5718.490.159.92
    Echocardiography0.3943.781.5528.48
    Colonoscopy39.3515.110.0030.83
    Gastroscopy20.0221.060.0029.02
    All 15 DM01 tests12.9528.508.8223.14
    Community services activityWest Sussex residentsSurrey and Sussex ICB
    Care contacts78,050309,615
    Referrals16,01566,930
    Patients with a contact19,77085,660

    Community services (residents of West Sussex), Jun 2026 (provisional). In June 2026 (provisional), 72.7% of community service contacts among Horsham residents were with adults aged 65 and over (56,740 of 78,050 contacts). These figures describe wider-system activity across the local authority district rather than PCN-level provision, reflecting non-acute care delivery where provider-level breakdowns are not captured.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    In 2025/26, QOF vaccination achievement spans 47.6 pp, from 39.1% at Billingshurst Surgery to 86.6% at Glebe Surgery (Henfield Medical Centre 48.7%, Steyning Health Centre 75.0%, England 55.2%). Clinical-domain achievement reaches 96.7% at Glebe Surgery, 100.0% at Henfield Medical Centre, and 100.0% at Steyning Health Centre (England 97.1%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Glebe Surgery1180.074.9%83.1%91.6%
    Steyning1040.076.4%74.9%86.5%
    Billingshurst1180.045.9%78.4%81.1%
    Henfield1020.048.1%78.3%77.1%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNHorshamAssetPCNHorsham
    Care homes (catchment)14 (519 beds)n/aSchools (catchment)45n/a
    Children's centres29Places of worship6393
    Libraries47Homelessness support (VCS)0no data
    Day centres (VCS)27Children and young people (VCS)n/a1
    Carers support groups (VCS)12Primary schools (LA maintained)1937
    Primary academies36Special schools23

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Standardise annual asthma review recall

    Asthma reviews reach 58.6% (below Horsham 62.4%, NHS Sussex Integrated Care Board 62.5%, England 65.7%), leaving 1,448 patients (about 1,400) of 3,494 unreviewed. For discussion: the PCN could run structured asthma recall using a single clinical template and flexible appointments, starting at the lowest-scoring practice. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    High-risk lipid therapy and formulary review

    Lipid therapy trails England in QRISK ≥ 20% (61.1% vs 63.6%), CKD (64.7% vs 70.3%), and diabetes with CVD (79.7% vs 84.4%); 104,322 items at £2.30 cost £45,902 more than at England's £1.86 unit cost. Moderate effort to run.

    Evidence base: delivery measure for eight care processes and three treatment targets; shortfall here is what shows up later as emergency admission.

    Policy anchor: NHS Diabetes Prevention Programme and the eight care processes / three treatment targets.

    Option 3

    Pre-school booster and MMR2 recall

    In Q1 2025/26 (cohort 108), age-5 coverage trails the 95.0% target by 7 pp for MMR2 (88.0%) and 8 pp for 4-in-1 (87.0%), with an 8 pp MMR1-to-MMR2 drop at Steyning Health Centre. Low cost, quick to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Anticipatory care and frailty review (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Condition smoking cessation recall (p4)Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Hypertension control optimisation (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school immunisation recall outreach (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cancer register review (p7)Cancer: QOF prevalenceCore20PLUS5, 75% stage 1–2 by 2028PCN
    Telephone access and triage review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Standardise annual asthma review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN & Practice
    Option 2 · High-risk lipid therapy and formulary review (p12)Patients with QRISK ≥ 20% treated with lipid lowering therapy · CKD patients treated with lipid lowering therapy · Patients with diabetes and a history of CVD (excl. haem. stroke) treated with a statin (denominator incl. PCAs)NHS Long Term Plan (diabetes) and National Diabetes AuditPCN
    Option 3 · Pre-school booster and MMR2 recall (p12)MMR dose 1 coverage at 24 months · MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15